Merlin Thomas (Monash University)

Curriculum Vitae

Educational Background & Professional Career
Name	Merlin Thomas
Country	Australia
Affiliation	Monash University
Department	Biochemistry & Molecular Biology
MB ChB (with distinction) University of Otago (NZ) PhD University of Melbourne Fellow of the Royal Australasian College of Physicians Fellow of the Australian Academy of Medical Science
Research Interests
Diabetic complications, Diabetic Kidney Disease, Alternative Splicing, RNA Therapeutics, Receptor for Advanced Glycation End-products
Publications
Thomas MC, Coughlan MT, Cooper ME.The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes. Cell Metab. 2023 Feb 7;35(2):253-273. Thomas MC, Cherney DZI. The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure. Diabetologia. 2018 Oct;61(10):2098-2107. Thomas MC, Cooper ME. The GLP-1 receptor agonist revolution comes to nephrology. Nat Rev Nephrol. 2024 Oct;20(10):637-638. Thomas MC. The potential and pitfalls of GLP-1 receptor agonists for renal protection in type 2 diabetes.Diabetes Metab. 2017 Apr;43 Suppl 1:2S20-2S27. Thomas MC, Zoungas S, Hanssen NMJ, McAuley SA, Cooper ME. Kidney Disease: The Forgotten Legacy of Type 1 Diabetes. Diabetes Care. 2025 Aug 1;48(8):1299-1308 Thomas MC, Brownlee M, Susztak K, Sharma K, Jandeleit-Dahm KA, Zoungas S, Rossing P, Groop PH, Cooper ME. Diabetic kidney disease. Nat Rev Dis Primers. 2015 Jul 30;1:15018.